Medicine
Taltz 80 mg/1 mL injection
Taltz 80 mg/1 mL injection is a prescription medicine containing Ixekizumab for subcutaneous use, marketed by Eli Lilly, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F). Once TALTZ has been stored at…
Key facts
- Active ingredient (INN)
- Ixekizumab
- Brand
- Taltz
- Strength
- 80 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 3 syringes of 1 mL, 1 syringe of 1 mL, 2 syringes of 1 mL and 1 more
- Marketing authorisation holder
- Eli Lilly
- Manufacturer
- Eli Lilly
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F). Once TALTZ has been stored at room temperature, do not return to the refrigerator and discard, if unused, within 5 days. If needed, patients/caregivers may store TALTZ at room temperature up to 30°C (86°F) for up to 5 days in the original carton to protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AC13 Ixekizumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 March 2016
- Identifiers
- RxCUI 1745103, 1745108, 1745112 +5DailyMed set ID ac96658a-d7dc-4c7c-8928-2adcdf4318b2NDC 0002-7724, 0002-1445Application BLA125521
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 syringe in 1 carton / 1 mL in 1 syringe | 0002-1445-09 | Eli Lilly | 22 March 2016 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 0002-1445-11 | Eli Lilly | 22 March 2016 |
| 2 syringe in 1 carton / 1 mL in 1 syringe | 0002-1445-27 | Eli Lilly | 22 March 2016 |
| 1 syringe in 1 carton / 1 mL in 1 syringe | 0002-7724-11 | Eli Lilly | 22 March 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ixekizumab
Clinical summary
Ixekizumab is an interleukin-17A antagonist indicated for the treatment of patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, among other approved uses. MedsAcross supplies Ixekizumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IxekizumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TALTZ prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
- Taltz: European public assessment report (EPAR) · European Medicines Agency
Need Taltz 80 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.